col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world


128 Results       Page 1

 [1] 
Springer Science and Business Media LLC: Cell Discovery
  original article Date Title Authors   All Authors
1 [GO] 2024―Dec―09 The comprehensive SARS-CoV-2 ‘hijackome’ knowledge base Sini Huuskonen, Xiaonan Liu, Ina Pöhner, Taras Redchuk, Kari Salokas, Rickard Lundberg, et al. (+17)
2 [GO] 2024―Nov―30 Structural and molecular basis of the epistasis effect in enhanced affinity between SARS-CoV-2 KP.3 and ACE2 Leilei Feng, Zhaoxi Sun, Yuchen Zhang, Fanchong Jian, Sijie Yang, Keely Xia, et al. (+5)
3 [GO] 2024―Aug―08 Structural basis for the interaction between human coronavirus HKU1 spike receptor binding domain and its receptor TMPRSS2 Xiaopan Gao, Kaixiang Zhu, Lin Wang, Kun Shang, Lei Hua, Bo Qin, et al. (+3)
4 [GO] 2024―Apr―09 Resistance mechanisms of SARS-CoV-2 3CLpro to the non-covalent inhibitor WU-04 Lijing Zhang, Xuping Xie, Hannan Luo, Runtong Qian, Yang Yang, Hongtao Yu, et al. (+3)
5 [GO] 2024―Feb―06 Potent and broadly neutralizing antibodies against sarbecoviruses induced by sequential COVID-19 vaccination Xiaoyu Zhao, Tianyi Qiu, Xiner Huang, Qiyu Mao, Yajie Wang, Rui Qiao, et al. (+22)
6 [GO] 2024―Jan―09 Fusogenicity of SARS-CoV-2 BA.2.86 subvariant and its sensitivity to the prokaryotic recombinant EK1 peptide Lijue Wang, Fanke Jiao, Hanxiao Jiang, Yitao Yang, Ziqi Huang, Qian Wang, et al. (+5)
7 [GO] 2023―Dec―08 Author Correction: A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD Shuo Liu, Zijing Jia, Jianhui Nie, Ziteng Liang, Jingshu Xie, Lei Wang, et al. (+4)
8 [GO] 2023―Dec―05 Multiple-cohort study of the elderly to determine the immunological characteristics and pathogenic mechanisms of severe community-acquired pneumonia caused by the low-virulence virus SARS-CoV-2 Omicron variant Tianyu Lu, Qiuhong Man, Shuai Xia, Xiaohang Liu, Yan Yan, Xueying Yu, et al. (+5)
9 [GO] 2023―Nov―11 VH-CH1 switch region-inserting multispecific antibody designs and their efficacy against SARS-CoV-2 in vitro and in vivo Lili Wu, Yue Gao, Dandan Yu, Sheng Liu, Runchu Zhao, Dezhi Liu, et al. (+9)
10 [GO] 2023―Nov―02 Cryo-EM structures of SARS-CoV-2 BA.2-derived subvariants spike in complex with ACE2 receptor Yaning Li, Chang Ren, Yaping Shen, Yuanyuan Zhang, Jin Chen, Jiangnan Zheng, et al. (+3)
11 [GO] 2023―Oct―09 Author Correction: Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses Xiuyuan Ou, Ge Xu, Pei Li, Yan Liu, Fuwen Zan, Pan Liu, et al. (+12)
12 [GO] 2023―Aug―18 Evolving spike mutations in SARS-CoV-2 Omicron variants facilitate evasion from breakthrough infection-acquired antibodies Shiqi Chen, Zehong Huang, Yue Guo, Huilin Guo, Lijuan Jian, Jin Xiao, et al. (+9)
13 [GO] 2023―Jul―28 Host susceptibility and structural and immunological insight of S proteins of two SARS-CoV-2 closely related bat coronaviruses Xiuyuan Ou, Ge Xu, Pei Li, Yan Liu, Fuwen Zan, Pan Liu, et al. (+12)
14 [GO] 2023―Jul―28 Impact of SARS-CoV-2 envelope protein mutations on the pathogenicity of Omicron XBB Yi Wang, Xiaoyan Pan, Hongying Ji, Xiaoli Zuo, Geng-Fu Xiao, Jia Li, et al. (+3)
15 [GO] 2023―Jul―28 Dosing interval regimen shapes potency and breadth of antibody repertoire after vaccination of SARS-CoV-2 RBD protein subunit vaccine Shuxin Guo, Yuxuan Zheng, Zhengrong Gao, Minrun Duan, Sheng Liu, Pan Du, et al. (+8)
16 [GO] 2023―Jun―27 Neutralization of SARS-CoV-2 BQ.1.1, CH.1.1, and XBB.1.5 by breakthrough infection sera from previous and recent waves in China Xun Wang, Shuai Jiang, Shujun Jiang, Xiangnan Li, Jingwen Ai, Ke Lin, et al. (+9)
17 [GO] 2023―Jun―17 A pangolin-origin SARS-CoV-2-related coronavirus: infectivity, pathogenicity, and cross-protection by preexisting immunity Xing-Yao Huang, Qi Chen, Meng-Xu Sun, Hang-Yu Zhou, Qing Ye, Wu Chen, et al. (+13)
18 [GO] 2023―Jun―15 Broad host tropism of ACE2-using MERS-related coronaviruses and determinants restricting viral recognition Chengbao Ma, Chen Liu, Qing Xiong, Mengxue Gu, Lulu Shi, Chunli Wang, et al. (+5)
19 [GO] 2023―Apr―20 A tissue specific-infection mouse model of SARS-CoV-2 Bo Yang, Chao Liu, Xiaohui Ju, Bingbing Wu, Zhuangfei Wang, Fucheng Dong, et al. (+8)
20 [GO] 2023―Apr―11 High-throughput screening of spike variants uncovers the key residues that alter the affinity and antigenicity of SARS-CoV-2 Yufeng Luo, Shuo Liu, Jiguo Xue, Ye Yang, Junxuan Zhao, Ying Sun, et al. (+11)
21 [GO] 2023―Apr―04 Comprehensive structural analysis reveals broad-spectrum neutralizing antibodies against SARS-CoV-2 Omicron variants Xiangyang Chi, Lingyun Xia, Guanying Zhang, Ximin Chi, Bangdong Huang, Yuanyuan Zhang, et al. (+9)
22 [GO] 2023―Feb―08 Long-term and effective neutralization against omicron sublineages elicited by four platform COVID-19 vaccines as a booster dose Yuemiao Zhang, Meng-Ting Luo, Qingqin Wu, Yun-Xia Wang, Xupu Ma, Guanghong Yan, et al. (+43)
23 [GO] 2023―Jan―23 Lyophilized mRNA-lipid nanoparticle vaccines with long-term stability and high antigenicity against SARS-CoV-2 Liangxia Ai, Yafei Li, Li Zhou, Wenrong Yao, Hao Zhang, Zhaoyu Hu, et al. (+28)
24 [GO] 2023―Jan―07 Biparatopic antibody BA7208/7125 effectively neutralizes SARS-CoV-2 variants including Omicron BA.1-BA.5 Yanqun Wang, An Yan, Deyong Song, Chuangchuang Dong, Muding Rao, Yuanzhu Gao, et al. (+35)
25 [GO] 2023―Jan―06 Extracellular vesicles mediate antibody-resistant transmission of SARS-CoV-2 Bingqing Xia, Xiaoyan Pan, Rong-Hua Luo, Xurui Shen, Shuangqu Li, Yi Wang, et al. (+14)
26 [GO] 2022―Dec―21 SARS-CoV-2 vaccination-infection pattern imprints and diversifies T cell differentiation and neutralizing response against Omicron subvariants Junxiang Wang, Kaiyi Li, Xinyue Mei, Jinpeng Cao, Jiaying Zhong, Peiyu Huang, et al. (+6)
27 [GO] 2022―Dec―09 COVID-19 vaccination boosts the potency and breadth of the immune response against SARS-CoV-2 among recovered patients in Wuhan Hong Liang, Xuanxuan Nian, Junzheng Wu, Dong Liu, Lu Feng, Jia Lu, et al. (+41)
28 [GO] 2022―Dec―09 A bispecific nanobody dimer broadly neutralizes SARS-CoV-1 & 2 variants of concern and offers substantial protection against Omicron via low-dose intranasal administration Huan Ma, Xinghai Zhang, Weihong Zeng, Junhui Zhou, Xiangyang Chi, Shaohong Chen, et al. (+13)
29 [GO] 2022―Nov―29 Antigenic characterization of SARS-CoV-2 Omicron subvariant BA.4.6 Aiste Dijokaite-Guraliuc, Raksha Das, Rungtiwa Nutalai, Daming Zhou, Alexander J. Mentzer, Chang Liu, et al. (+9)
30 [GO] 2022―Nov―16 Structures of ACE2-SIT1 recognized by Omicron variants of SARS-CoV-2 Yaping Shen, Jianhui Wang, Yaning Li, Yuanyuan Zhang, Ruilin Tian, Renhong Yan
31 [GO] 2022―Nov―01 Humoral responses against SARS-CoV-2 Omicron BA.2.11, BA.2.12.1 and BA.2.13 from vaccine and BA.1 serum Jiandong Huo, Aiste Dijokaite-Guraliuc, Rungtiwa Nutalai, Raksha Das, Daming Zhou, Alexander J. Mentzer, et al. (+5)
32 [GO] 2022―Oct―21 Cellular basis of enhanced humoral immunity to SARS-CoV-2 upon homologous or heterologous booster vaccination analyzed by single-cell immune profiling Jingwen Ai, Jingxin Guo, Haocheng Zhang, Yi Zhang, Haochen Yang, Ke Lin, et al. (+22)
33 [GO] 2022―Oct―07 Combating the SARS-CoV-2 Omicron (BA.1) and BA.2 with potent bispecific antibodies engineered from non-Omicron neutralizing antibodies Yingdan Wang, Xiang Zhang, Yunping Ma, Yanqun Wang, Wuqiang Zhan, Qinwen Zheng, et al. (+12)
34 [GO] 2022―Sep―30 SARS-CoV-2 Spike protein S2 subunit modulates γ-secretase and enhances amyloid-β production in COVID-19 neuropathy Guanqin Ma, Deng-Feng Zhang, Qing-Cui Zou, Xiaochun Xie, Ling Xu, Xiao-Li Feng, et al. (+9)
35 [GO] 2022―Sep―27 The Omicron BA.2.2.1 subvariant drove the wave of SARS-CoV-2 outbreak in Shanghai during spring 2022 Yun Ling, Gang Lu, Feng Liu, Yun Tan, Xiaoguang Xu, Dong Wei, et al. (+9)
36 [GO] 2022―Sep―09 Potential of angiotensin II receptor blocker telmisartan in reducing mortality among hospitalized patients with COVID-19 compared with recommended drugs Dengyuan Liu, Peng Wu, Wentao Gu, Cuihong Yang, Xinmeng Yang, Xingyu Deng, et al. (+3)
37 [GO] 2022―Sep―09 Surface translocation of ACE2 and TMPRSS2 upon TLR4/7/8 activation is required for SARS-CoV-2 infection in circulating monocytes Yi Yao, Kalpana Subedi, Tingting Liu, Namir Khalasawi, Carla Diana Pretto-Kernahan, Jesse William Wotring, et al. (+13)
38 [GO] 2022―Sep―08 Structural basis of a two-antibody cocktail exhibiting highly potent and broadly neutralizing activities against SARS-CoV-2 variants including diverse Omicron sublineages Xiaoman Li, Yongbing Pan, Qiangling Yin, Zejun Wang, Sisi Shan, Laixing Zhang, et al. (+19)
39 [GO] 2022―Sep―06 RNA G-quadruplex formed in SARS-CoV-2 used for COVID-19 treatment in animal models Geng Qin, Chuanqi Zhao, Yan Liu, Cheng Zhang, Guang Yang, Jie Yang, et al. (+6)
40 [GO] 2022―Aug―17 A broader neutralizing antibody against all the current VOCs and VOIs targets unique epitope of SARS-CoV-2 RBD Shuo Liu, Zijing Jia, Jianhui Nie, Ziteng Liang, Jingshu Xie, Lei Wang, et al. (+4)
41 [GO] 2022―Aug―10 Author Correction: Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs Bo Lu, Yi Yan, Liting Dong, Lingling Han, Yawei Liu, Junping Yu, et al. (+10)
42 [GO] 2022―Jul―25 Enhanced inflammation and suppressed adaptive immunity in COVID-19 with prolonged RNA shedding Xiaohua Tang, Rui Sun, Weigang Ge, Tingting Mao, Liujia Qian, Chongquan Huang, et al. (+26)
43 [GO] 2022―Jul―19 Heterotypic vaccination responses against SARS-CoV-2 Omicron BA.2 Zhenhao Fang, Lei Peng, Carolina Lucas, Qianqian Lin, Liqun Zhou, Luojia Yang, et al. (+25)
44 [GO] 2022―Jul―12 Broader-species receptor binding and structural bases of Omicron SARS-CoV-2 to both mouse and palm-civet ACE2s Linjie Li, Pu Han, Baihan Huang, Yufeng Xie, Weiwei Li, Di Zhang, et al. (+14)
45 [GO] 2022―Jun―30 A trifunctional peptide broadly inhibits SARS-CoV-2 Delta and Omicron variants in hamsters Hanjun Zhao, Kelvin Kai-Wang To, Hoiyan Lam, Chuyuan Zhang, Zheng Peng, Xinjie Meng, et al. (+7)
46 [GO] 2022―Jun―17 A bipotential organoid model of respiratory epithelium recapitulates high infectivity of SARS-CoV-2 Omicron variant Man Chun Chiu, Cun Li, Xiaojuan Liu, Yifei Yu, Jingjing Huang, Zhixin Wan, et al. (+15)
47 [GO] 2022―Jun―06 Novel cleavage sites identified in SARS-CoV-2 spike protein reveal mechanism for cathepsin L-facilitated viral infection and treatment strategies Miao-Miao Zhao, Yun Zhu, Li Zhang, Gongxun Zhong, Linhua Tai, Shuo Liu, et al. (+19)
48 [GO] 2022―May―18 Proteomic characterization of Omicron SARS-CoV-2 host response Jianfeng Bao, Rui Sun, Jingwen Ai, Liujia Qian, Fang Liu, Hongyu Wang, et al. (+10)
49 [GO] 2022―May―10 Non-adjuvanted interferon-armed RBD protein nasal drops protect airway infection from SARS-CoV-2 Yifan Lin, Jing Sun, Xuezhi Cao, Xiuye Wang, Xi Chen, Hairong Xu, et al. (+3)
50 [GO] 2022―May―10 SARS-CoV-2 Omicron variant virus isolates are highly sensitive to interferon treatment Denisa Bojkova, Tamara Rothenburger, Sandra Ciesek, Mark N. Wass, Martin Michaelis, Jindrich Cinatl
51 [GO] 2022―Apr―29 Treatment of SARS-CoV-2-induced pneumonia with NAD+ and NMN in two mouse models Yisheng Jiang, Yongqiang Deng, Huanhuan Pang, Tiantian Ma, Qing Ye, Qi Chen, et al. (+4)
52 [GO] 2022―Apr―21 Novel sarbecovirus bispecific neutralizing antibodies with exceptional breadth and potency against currently circulating SARS-CoV-2 variants and sarbecoviruses Yingdan Wang, Meiqin Liu, Yaping Shen, Yunping Ma, Xiang Li, Yuanyuan Zhang, et al. (+20)
53 [GO] 2022―Feb―15 Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2 Yu Liang, Jing Zhang, Run Yu Yuan, Mei Yu Wang, Peng He, Ji Guo Su, et al. (+29)
54 [GO] 2022―Feb―15 Broad ultra-potent neutralization of SARS-CoV-2 variants by monoclonal antibodies specific to the tip of RBD Hang Ma, Yingying Guo, Haoneng Tang, Chien-Te K. Tseng, Lei Wang, Huifang Zong, et al. (+44)
55 [GO] 2022―Feb―01 CoVac501, a self-adjuvanting peptide vaccine conjugated with TLR7 agonists, against SARS-CoV-2 induces protective immunity Yiru Long, Jianhua Sun, Tian-Zhang Song, Tingting Liu, Feng Tang, Xinxin Zhang, et al. (+32)
56 [GO] 2022―Feb―01 Robust induction of B cell and T cell responses by a third dose of inactivated SARS-CoV-2 vaccine Yihao Liu, Qin Zeng, Caiguanxi Deng, Mengyuan Li, Liubing Li, Dayue Liu, et al. (+10)
57 [GO] 2022―Jan―17 Reduced sensitivity of SARS-CoV-2 Omicron variant to antibody neutralization elicited by booster vaccination Xiaoqi Yu, Dong Wei, Wenxin Xu, Yulong Li, Xinxin Li, Xinxin Zhang, et al. (+3)
58 [GO] 2021―Dec―27 Author Correction: SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells Jinliang Wang, Guan Yang, Xinxin Wang, Zhiyuan Wen, Lei Shuai, Jie Luo, et al. (+11)
59 [GO] 2021―Dec―18 Heterologous prime-boost immunizations with chimpanzee adenoviral vectors elicit potent and protective immunity against SARS-CoV-2 infection Jiaojiao Liu, Kun Xu, Man Xing, Yue Zhuo, Jingao Guo, Meng Du, et al. (+13)
60 [GO] 2021―Dec―14 SARS-CoV-2 uses metabotropic glutamate receptor subtype 2 as an internalization factor to infect cells Jinliang Wang, Guan Yang, Xinxin Wang, Zhiyuan Wen, Lei Shuai, Jie Luo, et al. (+11)
61 [GO] 2021―Nov―30 Identification of oligosaccharyltransferase as a host target for inhibition of SARS-CoV-2 and its variants Yi-Jiao Huang, Hui Zhao, Xun Huang, Yong-Qiang Deng, Xiao-Feng Li, Qing Ye, et al. (+4)
62 [GO] 2021―Nov―30 Broad neutralization against SARS-CoV-2 variants induced by a next-generation protein vaccine V-01 Shiyu Sun, Xi Chen, Jingjing Lin, Junwen Ai, Jiaming Yang, Zhenxiang Hu, et al. (+2)
63 [GO] 2021―Nov―23 Cross-neutralization of SARS-CoV-2 Kappa and Delta variants by inactivated vaccine-elicited serum and monoclonal antibodies Lin Cheng, Shuo Song, Qing Fan, Senlin Shen, Haiyan Wang, Bing Zhou, et al. (+3)
64 [GO] 2021―Nov―09 Structure-based evidence for the enhanced transmissibility of the dominant SARS-CoV-2 B.1.1.7 variant (Alpha) Shuai Xia, Zuoling Wen, Lijue Wang, Qiaoshuai Lan, Fanke Jiao, Linhua Tai, et al. (+5)
65 [GO] 2021―Nov―09 Establishment of human distal lung organoids for SARS-CoV-2 infection Ting Wang, Ning Zhang, Shipan Fan, Lianzheng Zhao, Wanlu Song, Yuhuan Gong, et al. (+9)
66 [GO] 2021―Oct―26 Comprehensive investigations revealed consistent pathophysiological alterations after vaccination with COVID-19 vaccines Jiping Liu, Junbang Wang, Jinfang Xu, Han Xia, Yue Wang, Chunxue Zhang, et al. (+20)
67 [GO] 2021―Oct―26 SARS-CoV-2 exploits host DGAT and ADRP for efficient replication Shuofeng Yuan, Bingpeng Yan, Jianli Cao, Zi-Wei Ye, Ronghui Liang, Kaiming Tang, et al. (+9)
68 [GO] 2021―Oct―19 Isolation of a panel of ultra-potent human antibodies neutralizing SARS-CoV-2 and viral variants of concern Andrey A. Gorchakov, Sergey V. Kulemzin, Sergey V. Guselnikov, Konstantin O. Baranov, Tatyana N. Belovezhets, Ludmila V. Mechetina, et al. (+17)
69 [GO] 2021―Oct―07 Distinct BCR repertoires elicited by SARS-CoV-2 RBD and S vaccinations in mice Siyu Tian, Kai Ji, Meng Wang, Fengze Wang, Hao Wang, Weijin Huang, et al. (+2)
70 [GO] 2021―Sep―28 Dynamics of TCR repertoire and T cell function in COVID-19 convalescent individuals Lingjie Luo, Wenhua Liang, Jianfeng Pang, Gang Xu, Yingying Chen, Xinrong Guo, et al. (+16)
71 [GO] 2021―Sep―07 RBD-homodimer, a COVID-19 subunit vaccine candidate, elicits immunogenicity and protection in rodents and nonhuman primates Xiaoyan Pan, Jian Shi, Xue Hu, Yan Wu, Liang Zeng, Yanfeng Yao, et al. (+25)
72 [GO] 2021―Aug―31 Genome-wide association study of COVID-19 severity among the Chinese population Yuanfeng Li, Yuehua Ke, Xinyi Xia, Yahui Wang, Fanjun Cheng, Xinyi Liu, et al. (+21)
73 [GO] 2021―Aug―25 Increased morbidity of obese mice infected with mouse-adapted SARS-CoV-2 Ya-Nan Zhang, Zhe-Rui Zhang, Hong-Qing Zhang, Xiao-Dan Li, Jia-Qi Li, Qiu-Yan Zhang, et al. (+7)
74 [GO] 2021―Aug―24 Pyroptosis of syncytia formed by fusion of SARS-CoV-2 spike and ACE2-expressing cells Huabin Ma, Zhoujie Zhu, Huaipeng Lin, Shanshan Wang, Peipei Zhang, Yanguo Li, et al. (+4)
75 [GO] 2021―Aug―18 Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection Jinkai Zang, Yuanfei Zhu, Yu Zhou, Chenjian Gu, Yufang Yi, Shuxia Wang, et al. (+13)
76 [GO] 2021―Aug―17 Molecular determinants for regulation of G3BP1/2 phase separation by the SARS-CoV-2 nucleocapsid protein Wenjie Huang, Xiaohui Ju, Min Tian, Xiaoyu Li, Yanying Yu, Qingxiang Sun, et al. (+2)
77 [GO] 2021―Aug―17 Systematic profiling of SARS-CoV-2-specific IgG responses elicited by an inactivated virus vaccine identifies peptides and proteins for predicting vaccination efficacy Ming-Liang Ma, Da-Wei Shi, Yang Li, Wei Hong, Dan-Yun Lai, Jun-Biao Xue, et al. (+20)
78 [GO] 2021―Aug―17 Establishment of a humanized swine model for COVID-19 Xuguang Du, Zihang Guo, Wenhui Fan, Tang Hai, Fei Gao, Pan Li, et al. (+9)
79 [GO] 2021―Aug―17 Humoral responses in naive or SARS-CoV-2 experienced individuals vaccinated with an inactivated vaccine Pai Peng, Hai-jun Deng, Jie Hu, Xiao-yu Wei, Jian-jiang Xue, Ting-ting Li, et al. (+10)
80 [GO] 2021―Aug―12 Potent prophylactic and therapeutic efficacy of recombinant human ACE2-Fc against SARS-CoV-2 infection in vivo Zhaoyong Zhang, Eric Zeng, Lu Zhang, Weiming Wang, Yingkang Jin, Jiye Sun, et al. (+21)
81 [GO] 2021―Aug―04 Dysregulated hematopoiesis in bone marrow marks severe COVID-19 Xin Wang, Yanling Wen, Xiaowei Xie, Yang Liu, Xiaohua Tan, Qingxian Cai, et al. (+16)
82 [GO] 2021―Jul―27 ScRNA-seq revealed the kinetic of nasopharyngeal immune responses in asymptomatic COVID-19 carriers Furong Qi, Gang Xu, Xuejiao Liao, Fuxiang Wang, Jing Yuan, Haiyan Wang, et al. (+4)
83 [GO] 2021―Jul―27 Author Correction: Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication Wen Juan Tu, Robert D. McCuaig, Michelle Melino, Daniel J. Rawle, Thuy T. Le, Kexin Yan, et al. (+13)
84 [GO] 2021―Jul―27 Screening of potent neutralizing antibodies against SARS-CoV-2 using convalescent patients-derived phage-display libraries Yongbing Pan, Jianhui Du, Jia Liu, Hai Wu, Fang Gui, Nan Zhang, et al. (+18)
85 [GO] 2021―Jul―20 Three epitope-distinct human antibodies from RenMab mice neutralize SARS-CoV-2 and cooperatively minimize the escape of mutants Jianhui Nie, Jingshu Xie, Shuo Liu, Jiajing Wu, Chuan Liu, Jianhui Li, et al. (+11)
86 [GO] 2021―Jul―20 hACE2 Fc-neutralization antibody cocktail provides synergistic protection against SARS-CoV-2 and its spike RBD variants Junli Liu, Qi Chen, Shumin Yang, Ying Li, Yang Dou, Yong-Qiang Deng, et al. (+10)
87 [GO] 2021―Jul―06 A virus-derived microRNA-like small RNA serves as a serum biomarker to prioritize the COVID-19 patients at high risk of developing severe disease Zheng Fu, Jian Wang, Zheng Wang, Ying Sun, Jian Wu, Yongchen Zhang, et al. (+8)
88 [GO] 2021―Jul―06 SARS-CoV-2 infection in the mouse olfactory system Qing Ye, Jia Zhou, Qi He, Rui-Ting Li, Guan Yang, Yao Zhang, et al. (+13)
89 [GO] 2021―Jun―15 Potential transmission chains of variant B.1.1.7 and co-mutations of SARS-CoV-2 Jingsong Zhang, Yang Zhang, Jun-Yan Kang, Shuiye Chen, Yongqun He, Benhao Han, et al. (+5)
90 [GO] 2021―Jun―08 Integrating longitudinal clinical laboratory tests with targeted proteomic and transcriptomic analyses reveal the landscape of host responses in COVID-19 Yun Tan, Wei Zhang, Zhaoqin Zhu, Niu Qiao, Yun Ling, Mingquan Guo, et al. (+22)
91 [GO] 2021―May―25 SARS-CoV-2 nucleocapsid protein impairs stress granule formation to promote viral replication Zhou-Qin Zheng, Su-Yun Wang, Zhi-Sheng Xu, Yu-Zhi Fu, Yan-Yi Wang
92 [GO] 2021―May―24 Targeting novel LSD1-dependent ACE2 demethylation domains inhibits SARS-CoV-2 replication Wen Juan Tu, Robert D. McCuaig, Michelle Melino, Daniel J. Rawle, Thuy T. Le, Kexin Yan, et al. (+13)
93 [GO] 2021―May―04 The SARS-CoV-2 protein ORF3a inhibits fusion of autophagosomes with lysosomes Yabin Zhang, Hao Sun, Rongjuan Pei, Binli Mao, Zhenyu Zhao, Huihui Li, et al. (+2)
94 [GO] 2021―May―03 Author Correction: Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension Lei-Ke Zhang, Yuan Sun, Haolong Zeng, Qingxing Wang, Xiaming Jiang, Wei-Juan Shang, et al. (+10)
95 [GO] 2021―Apr―13 Characterization of respiratory microbial dysbiosis in hospitalized COVID-19 patients Huanzi Zhong, Yanqun Wang, Zhun Shi, Lu Zhang, Huahui Ren, Weiqun He, et al. (+27)
96 [GO] 2021―Apr―13 Distinct uptake, amplification, and release of SARS-CoV-2 by M1 and M2 alveolar macrophages Jiadi Lv, Zhenfeng Wang, Yajin Qu, Hua Zhu, Qiangqiang Zhu, Wei Tong, et al. (+12)
97 [GO] 2021―Apr―06 Functional comparison of SARS-CoV-2 with closely related pangolin and bat coronaviruses Jianhui Nie, Qianqian Li, Li Zhang, Yang Cao, Yue Zhang, Tao Li, et al. (+18)
98 [GO] 2021―Mar―30 Integrated characterization of SARS-CoV-2 genome, microbiome, antibiotic resistance and host response from single throat swabs Bo Lu, Yi Yan, Liting Dong, Lingling Han, Yawei Liu, Junping Yu, et al. (+10)
99 [GO] 2021―Mar―25 Immune memory in convalescent patients with asymptomatic or mild COVID-19 Quan-Xin Long, Yan-Jun Jia, Xin Wang, Hai-Jun Deng, Xiao-Xia Cao, Jun Yuan, et al. (+15)
100 [GO] 2021―Mar―23 SARS-CoV-2 cell tropism and multiorgan infection Jia Liu, Yufeng Li, Qian Liu, Qun Yao, Xi Wang, Huanyu Zhang, et al. (+9)
101 [GO] 2021―Jan―28 N6-methyladenosine regulates RNA abundance of SARS-CoV-2 Ting Zhang, Ying Yang, Zichun Xiang, Chun-Chun Gao, Wenjing Wang, Conghui Wang, et al. (+10)
102 [GO] 2021―Jan―21 SARS-CoV-2 nucleocapsid protein undergoes liquid-liquid phase separation into stress granules through its N-terminal intrinsically disordered region Jia Wang, Chengrui Shi, Qun Xu, Hang Yin
103 [GO] 2020―Dec―22 Calcium channel blocker amlodipine besylate therapy is associated with reduced case fatality rate of COVID-19 patients with hypertension Lei-Ke Zhang, Yuan Sun, Haolong Zeng, Qingxing Wang, Xiaming Jiang, Wei-Juan Shang, et al. (+10)
104 [GO] 2020―Nov―13 Infection of human sweat glands by SARS-CoV-2 Jia Liu, Yufeng Li, Liang Liu, Xudong Hu, Xi Wang, Hengrui Hu, et al. (+3)
105 [GO] 2020―Nov―10 Initial whole-genome sequencing and analysis of the host genetic contribution to COVID-19 severity and susceptibility Fang Wang, Shujia Huang, Rongsui Gao, Yuwen Zhou, Changxiang Lai, Zhichao Li, et al. (+21)
106 [GO] 2020―Nov―04 Heparan sulfate assists SARS-CoV-2 in cell entry and can be targeted by approved drugs in vitro Qi Zhang, Catherine Zhengzheng Chen, Manju Swaroop, Miao Xu, Lihui Wang, Juhyung Lee, et al. (+11)
107 [GO] 2020―Oct―29 Antihypertensive drugs are associated with reduced fatal outcomes and improved clinical characteristics in elderly COVID-19 patients Feifei Yan, Fengming Huang, Jun Xu, Penghui Yang, Yuhao Qin, Jingjun Lv, et al. (+11)
108 [GO] 2020―Oct―29 Patient-derived SARS-CoV-2 mutations impact viral replication dynamics and infectivity in vitro and with clinical implications in vivo Hangping Yao, Xiangyun Lu, Qiong Chen, Kaijin Xu, Yu Chen, Minghui Cheng, et al. (+13)
109 [GO] 2020―Oct―27 Sensitivity and specificity of SARS-CoV-2 S1 subunit in COVID-19 serology assays Ying Tian, Chaoyang Lian, Yingying Chen, Dong Wei, Xinxin Zhang, Yun Ling, et al. (+2)
110 [GO] 2020―Oct―20 The differential immune responses to COVID-19 in peripheral and lung revealed by single-cell RNA sequencing Gang Xu, Furong Qi, Hanjie Li, Qianting Yang, Haiyan Wang, Xin Wang, et al. (+7)
111 [GO] 2020―Oct―13 Sunitinib reduces the infection of SARS-CoV, MERS-CoV and SARS-CoV-2 partially by inhibiting AP2M1 phosphorylation Pei-Gang Wang, Dong-Jiang Tang, Zhan Hua, Zai Wang, Jing An
112 [GO] 2020―Sep―30 Broad host range of SARS-CoV-2 and the molecular basis for SARS-CoV-2 binding to cat ACE2 Lili Wu, Qian Chen, Kefang Liu, Jia Wang, Pengcheng Han, Yanfang Zhang, et al. (+13)
113 [GO] 2020―Sep―15 Temporal antibody responses to SARS-CoV-2 in patients of coronavirus disease 2019 Min Huang, Qing-Bin Lu, Han Zhao, Yulan Zhang, Zhiwei Sui, Liqun Fang, et al. (+5)
114 [GO] 2020―Sep―15 SARS-CoV-2 N protein antagonizes type I interferon signaling by suppressing phosphorylation and nuclear translocation of STAT1 and STAT2 Jingfang Mu, Yaohui Fang, Qi Yang, Ting Shu, An Wang, Muhan Huang, et al. (+4)
115 [GO] 2020―Sep―11 Decreased HD-MIR2911 absorption in human subjects with the SIDT1 polymorphism fails to inhibit SARS-CoV-2 replication Zhen Zhou, Yu Zhou, Xia-Ming Jiang, Yanbo Wang, Xi Chen, Gengfu Xiao, et al. (+4)
116 [GO] 2020―Sep―03 Immunization with the receptor-binding domain of SARS-CoV-2 elicits antibodies cross-neutralizing SARS-CoV-2 and SARS-CoV without antibody-dependent enhancement Jinkai Zang, Chenjian Gu, Bingjie Zhou, Chao Zhang, Yong Yang, Shiqi Xu, et al. (+9)
117 [GO] 2020―Aug―13 Survival of SARS-COV-2 under liquid medium, dry filter paper and acidic conditions Zhiping Sun, Xia Cai, Chenjian Gu, Rong Zhang, Wendong Han, Yun Qian, et al. (+7)
118 [GO] 2020―Aug―05 Absorbed plant MIR2911 in honeysuckle decoction inhibits SARS-CoV-2 replication and accelerates the negative conversion of infected patients Li-Kun Zhou, Zhen Zhou, Xia-Ming Jiang, Yishan Zheng, Xi Chen, Zheng Fu, et al. (+4)
119 [GO] 2020―Jul―24 Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro Paul S. Kwon, Hanseul Oh, Seok-Joon Kwon, Weihua Jin, Fuming Zhang, Keith Fraser, et al. (+3)
120 [GO] 2020―Jun―19 Author Correction: Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing Wen Wen, Wenru Su, Hao Tang, Wenqing Le, Xiaopeng Zhang, Yingfeng Zheng, et al. (+12)
121 [GO] 2020―May―27 Single-copy sensitive, field-deployable, and simultaneous dual-gene detection of SARS-CoV-2 RNA via modified RT-RPA Simin Xia, Xi Chen
122 [GO] 2020―May―18 SARS-CoV-2 detection with CRISPR diagnostics Lu Guo, Xuehan Sun, Xinge Wang, Chen Liang, Haiping Jiang, Qingqin Gao, et al. (+10)
123 [GO] 2020―May―04 Immune cell profiling of COVID-19 patients in the recovery stage by single-cell sequencing Wen Wen, Wenru Su, Hao Tang, Wenqing Le, Xiaopeng Zhang, Yingfeng Zheng, et al. (+12)
124 [GO] 2020―May―02 The anti-influenza virus drug, arbidol is an efficient inhibitor of SARS-CoV-2 in vitro Xi Wang, Ruiyuan Cao, Huanyu Zhang, Jia Liu, Mingyue Xu, Hengrui Hu, et al. (+10)
125 [GO] 2020―Mar―18 Hydroxychloroquine, a less toxic derivative of chloroquine, is effective in inhibiting SARS-CoV-2 infection in vitro Jia Liu, Ruiyuan Cao, Mingyue Xu, Xi Wang, Huanyu Zhang, Hengrui Hu, et al. (+4)
126 [GO] 2020―Mar―16 Network-based drug repurposing for novel coronavirus 2019-nCoV/SARS-CoV-2 Yadi Zhou, Yuan Hou, Jiayu Shen, Yin Huang, William Martin, Feixiong Cheng
127 [GO] 2020―Feb―24 Comparative genetic analysis of the novel coronavirus (2019-nCoV/SARS-CoV-2) receptor ACE2 in different populations Yanan Cao, Lin Li, Zhimin Feng, Shengqing Wan, Peide Huang, Xiaohui Sun, et al. (+4)
128 [GO] 2020―Feb―24 Phase-adjusted estimation of the number of Coronavirus Disease 2019 cases in Wuhan, China Huwen Wang, Zezhou Wang, Yinqiao Dong, Ruijie Chang, Chen Xu, Xiaoyue Yu, et al. (+9)
 [1] 

128 Results       Page 1


[de][en]

Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.028 sec